RecruitingPhase 3NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Sponsor: Eli Lilly and Company
Austin, TX · Beaumont, TX · Houston, TX · +49 more sites
1 recruiting alzheimer's disease studies with a site in Shavano Park, TX.
All trials in Shavano Park, TX · All Alzheimer's Disease trials
Sponsor: Eli Lilly and Company
Austin, TX · Beaumont, TX · Houston, TX · +49 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.